Strata Oncology to Help Identify Patients for NCI-MATCH Precision Medicine Study

Launched in 2015, NCI-MATCH is testing the efficacy of cancer treatments that are selected based on the genomic markers driving patients’ tumors, regardless of cancer type. Strata said it will identify patients for potential enrollment in the study’s various treatment arms through a network of 11 healthcare systems that are using the company’s StrataNGS 87-gene assay to link patients with clinical trials of targeted cancer therapies.

Source: https://www.genomeweb.com/cancer/strata-oncology-help-identify-patients-nci-match-precision-medicine-study